Elevated levels of the eosinophil granule major basic protein in the sputum of patients with bronchial asthma.

PubWeight™: 1.85‹?› | Rank: Top 3%

🔗 View Article (PMID 7230899)

Published in Mayo Clin Proc on June 01, 1981

Authors

E Frigas, D A Loegering, G O Solley, G M Farrow, G J Gleich

Articles citing this

Eosinophilic gastroenteritis: a clinicopathological study of patients with disease of the mucosa, muscle layer, and subserosal tissues. Gut (1990) 4.60

The effect of airway epithelium on smooth muscle contractility in bovine trachea. Br J Pharmacol (1985) 1.98

Activation of basophil and mast cell histamine release by eosinophil granule major basic protein. J Exp Med (1983) 1.69

Human eosinophil major basic protein is an endogenous allosteric antagonist at the inhibitory muscarinic M2 receptor. J Clin Invest (1993) 1.53

Antigen challenge induces pulmonary airway eosinophil accumulation and airway hyperreactivity in sensitized guinea-pigs: the effect of anti-asthma drugs. Br J Pharmacol (1990) 1.45

What targeting eosinophils has taught us about their role in diseases. J Allergy Clin Immunol (2010) 1.33

Pretreatment with antibody to eosinophil major basic protein prevents hyperresponsiveness by protecting neuronal M2 muscarinic receptors in antigen-challenged guinea pigs. J Clin Invest (1997) 1.33

Eosinophil-mediated injury to lung parenchymal cells and interstitial matrix. A possible role for eosinophils in chronic inflammatory disorders of the lower respiratory tract. J Clin Invest (1984) 1.29

Function of pulmonary M2 muscarinic receptors in antigen-challenged guinea pigs is restored by heparin and poly-L-glutamate. J Clin Invest (1992) 1.28

Eosinophils in the pathogenesis of allergic airways disease. Cell Mol Life Sci (2007) 1.26

Cutaneous late-phase response to allergen. Mediator release and inflammatory cell infiltration. J Clin Invest (1989) 1.23

Mature eosinophils stimulated to develop in human cord blood mononuclear cell cultures supplemented with recombinant human interleukin-5. Part I. Piecemeal degranulation of specific granules and distribution of Charcot-Leyden crystal protein. Am J Pathol (1991) 1.21

Ovalbumin sensitization changes the inflammatory response to subsequent parainfluenza infection. Eosinophils mediate airway hyperresponsiveness, m(2) muscarinic receptor dysfunction, and antiviral effects. J Exp Med (1999) 1.19

Localization of eosinophil granule major basic protein in human basophils. J Exp Med (1983) 1.16

Allergen-specific IgG1 and IgG3 through Fc gamma RII induce eosinophil degranulation. J Clin Invest (1995) 1.14

Eosinophil accumulation in pulmonary airways of guinea-pigs induced by exposure to an aerosol of platelet-activating factor: effect of anti-asthma drugs. Br J Pharmacol (1990) 1.14

Cytokines. 3. Cytokines in asthma. Thorax (1993) 1.12

An essential role for interleukin-5 and eosinophils in helminth-induced airway hyperresponsiveness. Infect Immun (1998) 1.12

Effect of oral glucocorticoid treatment on serum inflammatory markers in acute asthma. Arch Dis Child (2000) 1.04

Human eosinophil-granule major basic protein and synthetic polycations induce airway hyperresponsiveness in vivo dependent on bradykinin generation. J Clin Invest (1995) 1.04

Eosinophil cationic protein in inflammatory synovial effusions as evidence of eosinophil involvement. Ann Rheum Dis (1984) 1.01

Sputum and ciliary inhibition in asthma. Thorax (1982) 1.00

Isolation of a complementary DNA clone encoding a precursor to human eosinophil major basic protein. J Exp Med (1988) 0.97

Acute tropical pulmonary eosinophilia. Characterization of the lower respiratory tract inflammation and its response to therapy. J Clin Invest (1987) 0.97

Localization of a molecule immunochemically similar to eosinophil major basic protein in human placenta. J Exp Med (1984) 0.96

Short ragweed allergen induces eosinophilic lung disease in HLA-DQ transgenic mice. J Clin Invest (1999) 0.95

Pulmonary neuronal M2 muscarinic receptor function in asthma and animal models of hyperreactivity. Thorax (1998) 0.91

Asthma: eosinophil disease, mast cell disease, or both? Allergy Asthma Clin Immunol (2008) 0.88

Eosinophils in fungus-associated allergic pulmonary disease. Front Pharmacol (2013) 0.87

Eosinophil involvement in rheumatoid arthritis as reflected by elevated serum levels of eosinophil cationic protein. Clin Exp Immunol (1985) 0.85

Eosinophil granule-derived major basic protein induces IL-8 expression in human intestinal myofibroblasts. Clin Exp Immunol (2000) 0.83

Conjunctival provocative tests: a model of human ocular allergy. Trans Am Ophthalmol Soc (1989) 0.82

Bronchoalveolar lavage in the cat: cytological findings. Can J Vet Res (1989) 0.82

Interleukin-12 suppresses filaria-induced pulmonary eosinophilia, deposition of major basic protein and airway hyperresponsiveness. Parasite Immunol (1998) 0.81

Selective inflammatory response induced by intratracheal and intravenous administration of poly-L-arginine in guinea pig lungs. Inflammation (1999) 0.80

The role of eosinophils in asthma. Lung (1990) 0.79

How can microarrays unlock asthma? J Allergy (Cairo) (2012) 0.78

Localization of eosinophil major basic protein onto eggs of Schistosoma mansoni in human pathologic tissue. Am J Pathol (1988) 0.78

Update on reslizumab for eosinophilic asthma. Expert Opin Biol Ther (2015) 0.78

Human eosinophil major basic protein augments bronchoconstriction induced by intravenous agonists in guinea pigs. Agents Actions (1993) 0.77

Articles by these authors

Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med (1996) 5.69

The eosinophilic leukocyte: structure and function. Adv Immunol (1986) 4.08

The diagnosis and incidence of allergic fungal sinusitis. Mayo Clin Proc (1999) 3.79

Measurement of IgE in normal and allergic serum by radioimmunoassay. J Lab Clin Med (1971) 3.47

Establishment of an immature mast cell line from a patient with mast cell leukemia. Leuk Res (1988) 3.47

Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity. Am Rev Respir Dis (1988) 3.45

Strategies of anti-cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples. Immunol Rev (1992) 3.42

Cytotoxic properties of the eosinophil major basic protein. J Immunol (1979) 3.29

Renal oncocytoma: a reappraisal of morphologic features with clinicopathologic findings in 80 cases. Am J Surg Pathol (1997) 3.11

An investigation of the cause of the eosinophilia-myalgia syndrome associated with tryptophan use. N Engl J Med (1990) 3.05

Hereditary angioedema: a broad review for clinicians. Arch Intern Med (2001) 2.92

Sudden-onset fatal asthma. A distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa? Am Rev Respir Dis (1993) 2.83

Damage to schistosomula of Schistosoma mansoni induced directly by eosinophil major basic protein. J Immunol (1979) 2.81

Cytotoxic effects of the guinea pig eosinophil major basic protein on tracheal epithelium. Lab Invest (1980) 2.70

3-(Phenylamino)alanine, a novel aniline-derived amino acid associated with the eosinophilia-myalgia syndrome: a link to the toxic oil syndrome? Mayo Clin Proc (1992) 2.64

Benign teratomas of the mediastinum. J Thorac Cardiovasc Surg (1983) 2.46

The eosinophil and the pathophysiology of asthma. J Allergy Clin Immunol (1986) 2.29

Identification by immunofluorescence of eosinophil granule major basic protein in lung tissues of patients with bronchial asthma. Lancet (1982) 2.21

The late phase of the immediate wheal and flare skin reaction. Its dependence upon IgE antibodies. J Clin Invest (1976) 2.19

Toxicity of eosinophil cationic proteins for guinea pig tracheal epithelium in vitro. Am Rev Respir Dis (1989) 2.08

The clinical spectrum of the eosinophilia-myalgia syndrome associated with L-tryptophan ingestion. Clinical features in 20 patients and aspects of pathophysiology. Ann Intern Med (1990) 2.06

Experience with ileostomies. Evaluation of long-term rehabilitation in 497 patients. Am J Surg (1970) 2.06

Cardiac localization of eosinophil-granule major basic protein in acute necrotizing myocarditis. N Engl J Med (1990) 2.05

Deposits of eosinophil granule proteins in cardiac tissues of patients with eosinophilic endomyocardial disease. Lancet (1987) 1.98

Comparative properties of the Charcot-Leyden crystal protein and the major basic protein from human eosinophils. J Clin Invest (1976) 1.96

Sarcomas and sarcomatoid and mixed malignant tumors of the kidney in adults. 3. Cancer (1968) 1.95

Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis. Am J Respir Crit Care Med (1998) 1.90

The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proc Natl Acad Sci U S A (1999) 1.90

Identification of a major basic protein in guinea pig eosinophil granules. J Exp Med (1973) 1.87

Purification of human eosinophil-derived neurotoxin. Proc Natl Acad Sci U S A (1981) 1.85

Molecular cloning of the human eosinophil peroxidase. Evidence for the existence of a peroxidase multigene family. J Exp Med (1989) 1.83

IgA-induced eosinophil degranulation. J Immunol (1989) 1.82

Association of the eosinophilia-myalgia syndrome with the ingestion of tryptophan. N Engl J Med (1990) 1.80

Dermal deposition of eosinophil-granule major basic protein in atopic dermatitis. Comparison with onchocerciasis. N Engl J Med (1985) 1.79

Eosinophilic myocarditis manifesting as myocardial infarction: early diagnosis and successful treatment. Mayo Clin Proc (1997) 1.78

Primary malignant lymphoma of the bladder. J Urol (1990) 1.77

Granulocyte/macrophage colony-stimulating factor and interleukin 3 release from human peripheral blood eosinophils and neutrophils. J Exp Med (1991) 1.77

Cytogenetic analysis of six renal oncocytomas and a chromophobe cell renal carcinoma. Evidence that -Y, -1 may be a characteristic anomaly in renal oncocytomas. Cancer Genet Cytogenet (1992) 1.73

Production of human immunoglobulin E antibody in vitro. J Immunol (1979) 1.73

Eosinophils 1992. Immunol Today (1992) 1.69

Activation of basophil and mast cell histamine release by eosinophil granule major basic protein. J Exp Med (1983) 1.69

Biochemical and functional similarities between human eosinophil-derived neurotoxin and eosinophil cationic protein: homology with ribonuclease. Proc Natl Acad Sci U S A (1986) 1.67

Ribonuclease activity associated with human eosinophil-derived neurotoxin and eosinophil cationic protein. J Immunol (1986) 1.65

Antibacterial properties of eosinophil major basic protein and eosinophil cationic protein. J Immunol (1989) 1.64

Chromophobe cell renal carcinoma: clinicopathological features of 50 cases. J Urol (1995) 1.63

Low-grade collecting duct carcinoma of the kidney: report of 13 cases of low-grade mucinous tubulocystic renal carcinoma of possible collecting duct origin. Urology (1997) 1.63

Bronchoalveolar cell profiles of asthmatic and nonasthmatic subjects. Am Rev Respir Dis (1987) 1.62

Physiochemical and biological properties of the major basic protein from guinea pig eosinophil granules. J Exp Med (1974) 1.61

Selective stimulation and purification of eosinophils and neutrophils from guinea pig peritoneal fluids. J Lab Clin Med (1973) 1.61

Evidence of ongoing mast cell and eosinophil degranulation in symptomatic asthma airway. J Allergy Clin Immunol (1991) 1.60

Human eosinophil major basic protein induces airway constriction and airway hyperresponsiveness in primates. J Clin Invest (1991) 1.60

Small cell anaplastic carcinoma of the prostate: a clinical, pathological and immunohistological study of 27 patients. J Urol (1992) 1.60

Eosinophil infiltration and degranulation in normal human tissue. Anat Rec (1998) 1.59

Interferon-alpha treatment of six patients with the idiopathic hypereosinophilic syndrome. Ann Intern Med (1994) 1.58

Tissue eosinophilia and eosinophil degranulation in syndromes associated with fibrosis. Am J Pathol (1992) 1.58

Urachal cancer: role of conservative surgery. Urology (1993) 1.57

Ursodeoxycholic acid inhibits eosinophil degranulation in patients with primary biliary cirrhosis. Hepatology (1999) 1.54

Human eosinophil major basic protein is an endogenous allosteric antagonist at the inhibitory muscarinic M2 receptor. J Clin Invest (1993) 1.53

The late phase of the immunoglobulin E-mediated reaction: a link between anaphylaxis and common allergic disease? J Allergy Clin Immunol (1982) 1.53

The incidence of multicentricity in renal cell carcinoma. J Urol (1991) 1.53

Benign papilloma or papillary carcinoma of the bladder? J Urol (1973) 1.52

Nodules, eosinophilia, rheumatism, dermatitis and swelling (NERDS): a novel eosinophilic disorder. Clin Exp Allergy (1993) 1.52

Human eosinophil major basic protein causes hyperreactivity of respiratory smooth muscle. Role of the epithelium. Am Rev Respir Dis (1988) 1.52

Migration of eosinophils through basement membrane components in vitro: role of matrix metalloproteinase-9. Am J Respir Cell Mol Biol (1997) 1.52

Antibody formation in dysgammaglobulinemia. J Clin Invest (1966) 1.50

Serum IgE in dermatitis and dermatosis: an analysis of 497 cases. Arch Dermatol (1977) 1.48

Induced sputum: validity of fluid-phase IL-5 measurement. J Allergy Clin Immunol (2000) 1.47

Elevated serum levels of the eosinophil granule major basic protein in patients with eosinophilia. J Clin Invest (1981) 1.46

Regulatory effect of cytokines on eosinophil degranulation. J Immunol (1990) 1.45

Ablation of immunity to Amblyomma americanum by anti-basophil serum: cooperation between basophils and eosinophils in expression of immunity to ectoparasites (ticks) in guinea pigs. J Immunol (1982) 1.45

Eosinophil cationic granule proteins impair thrombomodulin function. A potential mechanism for thromboembolism in hypereosinophilic heart disease. J Clin Invest (1993) 1.45

Response of six patients with idiopathic hypereosinophilic syndrome to interferon alfa. J Allergy Clin Immunol (1994) 1.44

Anaphylactic transfusion reactions associated with anti-IgA antibody. N Engl J Med (1969) 1.44

Distinctive cationic proteins of the human eosinophil granule: major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin. J Immunol (1983) 1.43

Removal of bronchoalveolar cells augments the late eosinophilic response to segmental allergen challenge. Clin Exp Allergy (2002) 1.41

Eosinophilic endomyocardial disease presenting as cyanosis, platypnea, and orthodeoxia. Ann Intern Med (1992) 1.41

Extensive eosinophil degranulation and peroxidase-mediated oxidation of airway proteins do not occur in a mouse ovalbumin-challenge model of pulmonary inflammation. J Immunol (2001) 1.40

Clinical significance of nuclear DNA ploidy pattern in nonseminomatous germ cell testicular tumors. Urology (1994) 1.39

The role of eosinophils in the pathogenesis of asthma. Curr Opin Immunol (1994) 1.38

Episodic angioedema associated with eosinophilia. N Engl J Med (1984) 1.38

Leiomyosarcoma of the prostate. Report of 23 cases. Cancer (1995) 1.38